DRAGANFLY INC (DPRO)

CA26142Q2053 - Common Stock

4.19  +1.24 (+42.03%)

After market: 4.5 +0.31 (+7.4%)

Fundamental Rating

1

Taking everything into account, DPRO scores 1 out of 10 in our fundamental rating. DPRO was compared to 65 industry peers in the Aerospace & Defense industry. DPRO has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, DPRO is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

DPRO had negative earnings in the past year.
In the past year DPRO has reported a negative cash flow from operations.
In the past 5 years DPRO always reported negative net income.
In the past 5 years DPRO always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of DPRO (-187.77%) is worse than 95.38% of its industry peers.
Industry RankSector Rank
ROA -187.77%
ROE N/A
ROIC N/A
ROA(3y)-170.28%
ROA(5y)-193.62%
ROE(3y)-2029.35%
ROE(5y)-1360.53%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 30.98%, DPRO is doing good in the industry, outperforming 75.38% of the companies in the same industry.
DPRO's Gross Margin has declined in the last couple of years.
DPRO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.91%
GM growth 5Y-14.11%

0

2. Health

2.1 Basic Checks

DPRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DPRO has been increased compared to 1 year ago.
Compared to 5 years ago, DPRO has less shares outstanding
DPRO has a worse debt/assets ratio than last year.

2.2 Solvency

DPRO has an Altman-Z score of -19.29. This is a bad value and indicates that DPRO is not financially healthy and even has some risk of bankruptcy.
DPRO has a Altman-Z score of -19.29. This is amonst the worse of the industry: DPRO underperforms 95.38% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -19.29
ROIC/WACCN/A
WACC7.83%

2.3 Liquidity

A Current Ratio of 0.69 indicates that DPRO may have some problems paying its short term obligations.
With a Current ratio value of 0.69, DPRO is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
DPRO has a Quick Ratio of 0.69. This is a bad value and indicates that DPRO is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DPRO (0.56) is worse than 86.15% of its industry peers.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.56

5

3. Growth

3.1 Past

DPRO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -247.96%.
Looking at the last year, DPRO shows a very negative growth in Revenue. The Revenue has decreased by -13.81% in the last year.
Measured over the past years, DPRO shows a very strong growth in Revenue. The Revenue has been growing by 36.43% on average per year.
EPS 1Y (TTM)-247.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.85%
Revenue 1Y (TTM)-13.81%
Revenue growth 3Y14.53%
Revenue growth 5Y36.43%
Sales Q2Q%-11.82%

3.2 Future

Based on estimates for the next years, DPRO will show a very negative growth in Earnings Per Share. The EPS will decrease by -38.90% on average per year.
The Revenue is expected to grow by 45.62% on average over the next years. This is a very strong growth
EPS Next Y-832.69%
EPS Next 2Y-67.09%
EPS Next 3Y-38.9%
EPS Next 5YN/A
Revenue Next Year-4.5%
Revenue Next 2Y42.42%
Revenue Next 3Y45.62%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DPRO. In the last year negative earnings were reported.
Also next year DPRO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as DPRO's earnings are expected to decrease with -38.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-67.09%
EPS Next 3Y-38.9%

0

5. Dividend

5.1 Amount

No dividends for DPRO!.
Industry RankSector Rank
Dividend Yield N/A

DRAGANFLY INC

NASDAQ:DPRO (11/29/2024, 7:28:03 PM)

After market: 4.5 +0.31 (+7.4%)

4.19

+1.24 (+42.03%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap14.61M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -187.77%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 30.98%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.69
Quick Ratio 0.56
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-247.96%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-832.69%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-13.81%
Revenue growth 3Y14.53%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y